These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious. Goldberg A, Confino-Cohen R. J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360 [Abstract] [Full Text] [Related]
6. [Results of hyposensitization with bee and wasp venom]. Adolph J, Dehnert I, Fischer JF, Wenz W. Z Erkr Atmungsorgane; 1986 May; 166(1):119-24. PubMed ID: 3953108 [Abstract] [Full Text] [Related]
7. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy. Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P. J Investig Allergol Clin Immunol; 2006 May; 16(2):79-85. PubMed ID: 16689180 [Abstract] [Full Text] [Related]
11. The value of immunotherapy with venom in children with allergy to insect stings. Valentine MD, Schuberth KC, Kagey-Sobotka A, Graft DF, Kwiterovich KA, Szklo M, Lichtenstein LM. N Engl J Med; 1990 Dec 06; 323(23):1601-3. PubMed ID: 2098016 [Abstract] [Full Text] [Related]
12. [Immunotherapy against hymenoptera venom: report of ten patients]. Guzmán M MA, Salinas L J, Toche P P, Marinovic M MA, Gallardo O AM. Rev Med Chil; 2007 Dec 06; 135(12):1566-71. PubMed ID: 18357358 [Abstract] [Full Text] [Related]
13. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy. Díez Gómez ML, Quirce Gancedo S, Juliá de Páramo B. Allergol Immunopathol (Madr); 1995 Dec 06; 23(6):277-84. PubMed ID: 8579006 [Abstract] [Full Text] [Related]
20. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy. Pereira-Santos MC, Baptista AP, Melo A, Alves RR, Soares RS, Pedro E, Pereira-Barbosa M, Victorino RM, Sousa AE. Clin Exp Allergy; 2008 Feb 06; 38(2):291-7. PubMed ID: 18070166 [Abstract] [Full Text] [Related] Page: [Next] [New Search]